Dyne Therapeutics, Inc. Employee Count
The employee counts Dyne Therapeutics, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 258; Filing 2026-03-02; Lease expense per employee $32,116.28.
- 2024-12-31: Employees (as filed) 191; Filing 2025-02-27; Lease expense per employee $40,387.43.
- 2023-12-31: Employees (as filed) 141; Filing 2024-03-05; Lease expense per employee $53,510.64.
- 2022-12-31: Employees (as filed) 123; Filing 2023-03-02; Lease expense per employee $60,089.43.
- Available history
- 2022-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 258 full-time | 2026-03-02 | $32,116.28 total lease cost |
| 2024-12-31 | 191 full-time | 2025-02-27 | $40,387.43 total lease cost |
| 2023-12-31 | 141 full-time | 2024-03-05 | $53,510.64 total lease cost |
| 2022-12-31 | 123 full-time | 2023-03-02 | $60,089.43 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |